CAR Treg-cell therapy (AZTherapies)

N/A

Report date: 2025/01/26 19:05:42

Base Information

Drug NameCAR Treg-cell therapy (AZTherapies)

Drug Alias NameCAR Treg-cell therapy (Smith Therapeutics)CAR-TREG

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionNeuroprotectantsImmunosuppressants

TargetsUpdating

Therapy Area/IndicationsNerve Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSmith Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAztherapies Inc

Inactive CompaniesSmith Therapeutics Inc

Active IndicationsNerve Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A